Direkt zum Seiteninhalt, zur Hauptnavigation, zur Unternavigation, zur Fußzeile.

Industry Partners

Since its founding days, immatics has fueled its growing business by partnering with academic institutions, hospitals, consulting companies and other businesses.

At present, the growing pipeline of tumor-specific antigens and antigenic peptides identified by immatics offers numerous opportunities for co-development of our product candidates by pharmaceutical and biotech companies.

Biopharmaceutical companies with a focus on oncology and strong interests especially in the fields of clinical development of active immunotherapy are welcome to contact us for finding out more about partnerships for co-development.


 

 

Partnering

Companies and institutions seeking to find out more about partnering opportunities with immatics can directly contact us through: